NCT05958316 Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
| NCT ID | NCT05958316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Symptoms and Signs |
| Study Type | INTERVENTIONAL |
| Enrollment | 126 participants |
| Start Date | 2024-01-04 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 126 participants in total. It began in 2024-01-04 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
Eligibility Criteria
Inclusion Criteria: * Has received at least 1 cycle of cancer treatment and is within 3 months of receiving that first cycle of treatment * Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles * Reports at least 1 symptom related to cancer and/or its treatment * Able to speak, read, and write English as required for completion of the C-SCAT and study measures Exclusion Criteria: \- Cognitive and/or physical inability to complete study measures.
Contact & Investigator
Ronald Elswick, PhD
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT05958316 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 29 Years, studying Symptoms and Signs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05958316 currently recruiting?
Yes, NCT05958316 is actively recruiting participants. Contact the research team at hodgesg@vcu.edu for enrollment information.
Where is the NCT05958316 trial being conducted?
This trial is being conducted at Kansas City, United States, Salt Lake City, United States, Salt Lake City, United States, Richmond, United States and 1 additional location.
Who is sponsoring the NCT05958316 clinical trial?
NCT05958316 is sponsored by Virginia Commonwealth University. The principal investigator is Ronald Elswick, PhD at Virginia Commonwealth University. The trial plans to enroll 126 participants.